Yeo AE - Search Results

1

Characterization of patients with chronic refractory gout who do and do not have clinically apparent tophi and their response to pegloticase.

Lawrence Edwards N, Singh JA, Troum O, Yeo AE, Lipsky PE. Lawrence Edwards N, et al. Among authors: yeo ae. Rheumatology (Oxford). 2019 Mar 6:kez017. doi: 10.1093/rheumatology/kez017. Online ahead of print. Rheumatology (Oxford). 2019. PMID: 30843588

2

Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase.

Mandell BF, Yeo AE, Lipsky PE. Mandell BF, et al. Among authors: yeo ae. Arthritis Res Ther. 2018 Dec 29;20(1):286. doi: 10.1186/s13075-018-1782-x. Arthritis Res Ther. 2018. PMID: 30594229 Free PMC article.

3

Pegloticase Treatment Significantly Decreases Blood Pressure in Patients With Chronic Gout.

Johnson RJ, Choi HK, Yeo AE, Lipsky PE. Johnson RJ, et al. Among authors: yeo ae. Hypertension. 2019 Jul;74(1):95-101. doi: 10.1161/HYPERTENSIONAHA.119.12727. Epub 2019 May 13. Hypertension. 2019. PMID: 31079535

4

Dissociation Between Clinical Benefit and Persistent Urate Lowering in Patients with Chronic Refractory Gout Treated with Pegloticase.

Pillinger MH, Fields TR, Yeo AE, Lipsky PE. Pillinger MH, et al. Among authors: yeo ae. J Rheumatol. 2020 Apr;47(4):605-612. doi: 10.3899/jrheum.190161. Epub 2019 Jun 15. J Rheumatol. 2020. PMID: 31203212 Clinical Trial.

5

Evaluation of Proposed Criteria for Remission and Evidence-Based Development of Criteria for Complete Response in Patients With Chronic Refractory Gout.

Schlesinger N, Edwards NL, Khanna PP, Yeo AE, Lipsky PE. Schlesinger N, et al. Among authors: yeo ae. ACR Open Rheumatol. 2019 May 23;1(4):236-243. doi: 10.1002/acr2.1025. eCollection 2019 Jun. ACR Open Rheumatol. 2019. PMID: 31777799 Free PMC article.

6

Post-hoc analysis of pegloticase pivotal trials in chronic refractory gout: relationship between fluctuations in plasma urate levels and acute flares.

Mandell BF, Fields TR, Edwards NL, Yeo AE, Lipsky PE. Mandell BF, et al. Among authors: yeo ae. Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1085-1092. doi: 10.55563/clinexprheumatol/b7jjnb. Epub 2021 Jan 6. Clin Exp Rheumatol. 2021. PMID: 33427618 Clinical Trial.

7

Pegloticase causes prolonged improvement in multiple disease parameters in patients with chronic refractory gout who maintain low serum urate levels.

Keenan RT, Yeo AE, Lipsky PE. Keenan RT, et al. Among authors: yeo ae. Clin Exp Rheumatol. 2022 May;40(5):1006-1010. doi: 10.55563/clinexprheumatol/3m095f. Epub 2022 Feb 25. Clin Exp Rheumatol. 2022. PMID: 35238750

8

Improvement in hepatic fibrosis estimated by Fibrosis-4 index in pegloticase treated chronic refractory gout patients.

Schlesinger N, Rustgi VK, Yeo AE, Lipsky PE. Schlesinger N, et al. Among authors: yeo ae. Clin Exp Rheumatol. 2023 Jan;41(1):60-66. doi: 10.55563/clinexprheumatol/1138gr. Epub 2022 Mar 23. Clin Exp Rheumatol. 2023. PMID: 35349415 Free article.

9

Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout.

Calabrese LH, Kavanaugh A, Yeo AE, Lipsky PE. Calabrese LH, et al. Among authors: yeo ae. Arthritis Res Ther. 2017 Aug 17;19(1):191. doi: 10.1186/s13075-017-1396-8. Arthritis Res Ther. 2017. PMID: 28818095 Free PMC article. Clinical Trial.

10

Development of a multivariable improvement measure for gout.

Schlesinger N, Edwards NL, Yeo AE, Lipsky PE. Schlesinger N, et al. Among authors: yeo ae. Arthritis Res Ther. 2020 Jun 29;22(1):164. doi: 10.1186/s13075-020-02254-4. Arthritis Res Ther. 2020. PMID: 32600452 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters